✦ LIBER ✦

21 Weekly paclitaxel and three weekly docetaxel appear active and well-tolerated in third and fourth-line advanced NSCLC patients

✍ Scribed by Pender, A.; Letsa, I.; Reid, A.; Waddell, T.; Nimako, K.; Tan, D.; Xynos, I.; Ayite, B.; Priest, K.; Watson, S.; Stewart, Z.; Severn, J.; Popat, S.; O'Brien, M.

Book ID: 118574962
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 44 KB
Volume: 75
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(12)70022-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A proper schedule of weekly paclitaxel a

A proper schedule of weekly paclitaxel and gemcitabine combination is highly active and very well tolerated in NSCLC patients

✍ De Pas, Tommaso; Putzu, Carlo; Curigliano, Giuseppe; Noberasco, Cristina; Sabrin 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 210 KB

O-1 A phase III trial comparing weekly a

O-1 A phase III trial comparing weekly and three weekly docetaxel in second line treatment of patients with advanced non small cell lung cancer (NSCLC)

✍ Schuette, Wolfgang; Nagel, Sylke; Lautenschlaeger, C.; Serke, Monika; Wollschlae 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Erratum to“A proper schedule of weekly p

Erratum to“A proper schedule of weekly paclitaxel and gemcitabine combination is highly active and very well tolerated in NSCLC patients” [Lung cancer 54 (2006) 359–364]

✍ De Pas, Tommaso; Putzu, Carlo; Curigliano, Giuseppe; Noberasco, Cristina; Bosell 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 87 KB